Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jennifer Arrondeau"'
Autor:
Diane Damotte, Sarah Warren, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Audrey Mansuet-Lupo, Jérôme Biton, Hanane Ouakrim, Marco Alifano, Claire Gervais, Audrey Bellesoeur, Nora Kramkimel, Camille Tlemsani, Barbara Burroni, Angéline Duche, Franck Letourneur, Han Si, Rebecca Halpin, Todd Creasy, Ronald Herbst, Xing Ren, Pascale Morel, Alessandra Cesano, François Goldwasser, Karen Leroy
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background The 18-gene tumor inflammation signature (TIS) is a clinical research assay that enriches for clinical benefit to immune checkpoint blockade. We evaluated its ability to predict clinical benefit of immunotherapy in cancer patients
Externí odkaz:
https://doaj.org/article/b75c5fd83d2d4639a48bed140c36dd2f
Autor:
Pascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, Jean-Philippe Durand, Elizabeth Fabre, Sixtine De Percin, Clémentine Vaquin Villeminey, Anne-Catherine Piketty, Nathalie Rassy, Guillaume Ulmann, Diane Damotte, Audrey Mansuet-Lupo, Frédérique Giraud, Marco Alifano, Marie Wislez, Jérôme Alexandre, Anne Jouinot, François Goldwasser
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103630- (2021)
Background: Immune checkpoint inhibitors (ICI) are dramatically active in a minority of non-small cell lung cancer (NSCLC) patients. We studied here the relationship between patients's metabolism and outcome under ICI. Methods: Metastatic NSCLC patie
Externí odkaz:
https://doaj.org/article/c752ad522f9e41baab6f8929446462cf
Autor:
Gaëlle Noé, Audrey Bellesoeur, Lisa Golmard, Audrey Thomas-Schoemann, Pascaline Boudou-Rouquette, Manuela Tiako Meyo, Alicja Puszkiel, Jennifer Arrondeau, Jérome Alexandre, François Goldwasser, Benoit Blanchet, Michel Vidal
Publikováno v:
Cancers, Vol 11, Iss 6, p 762 (2019)
In the era of precision medicine, research of biomarkers for identification of responders to nivolumab therapy is a major challenge. Peripheral blood mononuclear cells (PBMC) could be an interesting surrogate tissue for identifying pharmacodynamic bi
Externí odkaz:
https://doaj.org/article/3ff8f635137044148e5fd048bcde205c
Autor:
Hanane Ouakrim, P Morel, Angéline Duché, Marco Alifano, Diane Damotte, Pascaline Boudou-Rouquette, Camille Tlemsani, Sarah Warren, Jérôme Biton, Alessandra Cesano, Rebecca Halpin, Claire Gervais, Nora Kramkimel, Han Si, Jennifer Arrondeau, Todd Creasy, Audrey Bellesoeur, Barbara Burroni, Ronald Herbst, Franck Letourneur, Xing Ren, Audrey Mansuet-Lupo, Karen Leroy, François Goldwasser
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background The 18-gene tumor inflammation signature (TIS) is a clinical research assay that enriches for clinical benefit to immune checkpoint blockade. We evaluated its ability to predict clinical benefit of immunotherapy in cancer patients treated
Autor:
Diane Damotte, Marie Wislez, Anne-Catherine Piketty, Audrey Mansuet-Lupo, Sixtine De Percin, Pascaline Boudou-Rouquette, Clémentine Villeminey, François Goldwasser, Frédérique Giraud, Marco Alifano, Claire Gervais, J.-P. Durand, Anne Jouinot, Elizabeth Fabre, Jérôme Alexandre, Guillaume Ulmann, Jennifer Arrondeau, Nathalie Rassy
Publikováno v:
EBioMedicine, Vol 73, Iss, Pp 103630-(2021)
EBioMedicine
EBioMedicine
Background: Immune checkpoint inhibitors (ICI) are dramatically active in a minority of non-small cell lung cancer (NSCLC) patients. We studied here the relationship between patients's metabolism and outcome under ICI. Methods: Metastatic NSCLC patie
Autor:
Hortense, Gaultier De Saint Basile, Caroline, Poisson, Jennifer, Arrondeau, Pascaline, Boudou-Rouquette, François, Goldwasser, Eric, Tartour, Eléonore, De Guillebon
Publikováno v:
Bulletin du cancer. 105(12)
Physiological aging causes qualitative or quantitative immune system decline, also called immunosenescence. Older people with cancer are often ineligible for chemotherapy. The new immunotherapies (with PD1, PDL1 and CTLA4 checkpoint inhibitors) have
Autor:
Jennifer Arrondeau, François Goldwasser, Gervais Claire, Jérôme Biton, Franck Letourneur, Marco Alifano, Pascaline Boudou-Rouquette, Sarah H. Warren, Karen Leroy, Alessandra Cesano, Audrey Bellesoeur, Nora Kramkimel, P Morel, Angéline Duché, Hanane Ouakrim, Xing Ren, Audrey Lupo, Diane Damotte
Publikováno v:
Cancer Research. 78:4546-4546
Purpose of the study : The 18-gene Tumor Inflammation Signature (TIS) (Ayers et al, J Clin Invest 2017; 127:2930) is a clinical research assay that enriches for clinical response to immune checkpoint blockade. In this work, the performance of the TIS
Autor:
Benoît, Rousseau, Stéphane, Champiat, Delphine, Loirat, Jennifer, Arrondeau, Nathalie, Lemoine, Jean-Charles, Soria
Publikováno v:
Bulletin du cancer. 101(1)
New immunotherapies, also called "immune checkpoints", are promising and showed interesting antitumoral activities in particular in advanced setting of melanoma, clear cell renal cancer or non-small cell lung carcinoma. These treatments include ipili